CLINICAL_TRIALS
trial_result
· 2012-05-01
Clinical Trial Update: Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI [Phase 3]
Summary
Phase 3 clinical trial evaluating Apadenoson for detecting myocardial perfusion defects using SPECT MPI has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Coronary Artery Disease | Phase 3 | Status: TERMINATED